Home Markets Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy

Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy

Jun 15, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/novo-nordisk-ceo-to-testify-in-us-senate-hearing-on-high-cost-of-ozempic-wegovy-3485707

You May Also Like

Rupert Murdoch’s News Corp to sell Foxtel to Britain’s DAZN for $2.1 billion

Westpac admits to overcharging more than 24,000 customers in New Zealand

Malaysia’s 1MDB files legal claim against Amicorp Group seeking over $1 billion for alleged fraud 

Honda, Nissan set to announce launch of integration talks, sources say

Singapore’s TalkMed shares jump on $447 million privatization offer

Asia stocks rise on US inflation cheer; Honda-Nissan merger in focus